Source: Virtual Congress 2021 – Advances in asthma treatment



Rating:

Share or cite this content

Citations should be made in the following way:
C. Micheletto (Verona, Italy), M. Bilò (Ancona, Italy), L. Antonicelli (Ancona, Italy), F. De Michele (Napoli, Italy), A. Musarra (Reggio Calabria, Italy), A. Vagni (Garbagnate Milanese (MI), Italy). Evaluation of Asthma control and oral corticosteroids in Severe Asthma. 3529

Member's Comments

No comment yet.

Related content which might interest you: Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry. Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 When needed use of inhaled steroids in children with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma Source: International Congress 2018 – Asthma analysis Year: 2018 Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence? Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Allergic rhinitis does it have an impact on controller asthma therapy choice Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Assessment of mis-beliefs about bronchial asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Efficacy and safety of fluticasone propionate/formoterol in paediatric patients with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Metered-dose inhaler albuterol: Evaluation of efficacy and safety of increasing doses in children with acute wheezing Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Asthma Source: Eur Respir Monogr 2017; 77: 1-12 Year: 2017 Asthma Source: Eur Respir Monogr 2013; 62: 19-36 Year: 2013